Results for tag: "Solubility Enhancement Excipient"

The Solubility Enhancement Excipient market is a subset of the Pharmaceutical Intermediates market. It is composed of excipients, which are inactive ingredients used to improve the solubility of active pharmaceutical ingredients (APIs). These excipients are used to increase the bioavailability of APIs, allowing them to be absorbed more quickly and efficiently by the body. Excipients also help to stabilize APIs, preventing them from degrading or reacting with other substances. The Solubility Enhancement Excipient market is driven by the increasing demand for APIs in the pharmaceutical industry. As the demand for APIs increases, so does the need for excipients to improve their solubility and bioavailability. This has led to an increase in the number of companies offering solubility enhancement excipients. Some of the major players in this market include BASF, Evonik, Roquette, Ashland, and Merck KGaA. Show Less Read more